Reaching More Patients: Telemedicine’s Role in Obesity Management
Barriers to care may prevent some patients with obesity from seeking treatment; telemedicine could help.
Barriers to care may prevent some patients with obesity from seeking treatment; telemedicine could help.
Though GLP-1s are generally considered to be safe, we are still learning about the safety of the long-term use of GLP-1 medications.
There is growing evidence that suggests intentional weight loss mediated by lifestyle change or pharmacotherapies can reduce cancer risk in adults.
The use of GLP-1 for a binge eating disorder is evolving as a potentially transformative adjunctive approach for treatment.
While advancements such as GLP-1 medications and bariatric surgery have improved clinical outcomes, a persistent gap remains in the use of behavioral interventions for weight management.
It’s important to help patients understand that GLP-1 medications are valuable tools within a comprehensive strategy that also involves lifestyle change, as this approach is key to achieving long-term weight loss success.
Supporting GLP-1 patients with behavior change could improve GLP-1 adherence and long-term weight loss.
Mindfulness could complement diet, exercise, and pharmacological therapies when treating patients with type 2 diabetes.
Preliminary results for using semaglutide for binge eating are promising. Binge eating is characterized by compulsive and chronic overeating.1 Acknowledged as a formal diagnosis in 2013, Binge Eating Disorder (BED) is estimated to affect approximately 1.25 percent of women and…
When it comes to behavioral nutrition management, a patient-centered model that includes ongoing education, a nutrient-dense diet, and a process approach to behavior change can lead to success. For patients with type 2 diabetes, a multi-prong management approach that includes…